Session Information
-
WCLC 2018
19th World Conference on Lung Cancer
Conference Program for the 19th World Conference on Lung Cancer in Toronto, Canada
Download PDF of the Abstract Book: Click Here.
Presentation Date(s):- Sept 23 - 26, 2018
- Total Presentations: 2391
September 23 Sun
Sep 23 Monday
September 24 Mon
Sep 24 Tuesday
September 25 Tue
Sep 25 Wednesday
September 26 Wed
Sep 26
-
+
YI01 - Young Investigators Session
- 08:00 - 11:30
- 9/23/2018
- Location: Room 106
- Type: Young Investigator Session
- Track:
-
+
YI01.14 - How to write a Successful Grant Application
10:45 - 11:00 | Presenter: Dean A Fennell
- Abstract
No abstract available for this presentation
-
+
PL02 - Presidential Symposium - Top 5 Abstracts
- 08:15 - 09:45
- 9/25/2018
- Location: Plenary Hall
- Type: Plenary Session
- Track: Advanced NSCLC
-
+
PL02.09 - Nintedanib + Pemetrexed/Cisplatin in Patients with Unresectable MPM: Phase III Results from the LUME-Meso Trial
09:15 - 09:25 | Presenter: Giorgio Vittorio Scagliotti | Author(s): Rabab Gaafar, Anna K. Nowak, Takashi Nakano, Jan Van Meerbeeck, Sanjay Popat, Nicholas Vogelzang, Federica Grosso, Rasha Aboelhassan, Marko Jakopovic, Giovanni L Ceresoli, Paul Taylor, Francisco Orlandi, Dean A Fennell, Silvia Novello, Arnaud Scherpereel, Ute Von Wangenheim, Miyoung Kim, José Barrueco, Anne S. Tsao
- Abstract
Loading...
-
+
MA12 - Mesothelioma Surgery and Novel Targets for Prognosis and Therapy
- 10:30 - 12:00
- 9/25/2018
- Location: Room 202 BD
- Type: Mini Oral Abstract Session
- Track: Mesothelioma
-
+
MA12.05 - Phase 1 Study of HSP90 Inhibitor Ganetespib with Pemetrexed and Cisplatin/Carboplatin Chemotherapy for Pleural Mesothelioma
11:00 - 11:05 | Presenter: Dean A Fennell | Author(s): Sarah Danson, Martin Forster, Denis Talbot, Penella Woll, Jennifer Child, Yenting Ngai, Laura Farrelly, Allan Hackshaw, Annabel Sharkey, Sara Busacca, Robert Hastings, Dan Barnes, Marianne Nicolson, Paul Taylor, Samreen Ahmed, Graham Mark Wheeler
- Abstract
Loading...
-
+
P2.06 - Mesothelioma (Not CME Accredited Session)
- 16:45 - 18:00
- 9/25/2018
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track:
-
+
P2.06-09 - MiST3: A Phase II Study of Oral Selective AXL Inhibitor Bemcentinib (BGB324) in Combination with Pembrolizumab in pts with Malignant Mesothelioma
16:45 - 18:00 | Presenter: Dean A Fennell | Author(s): Matthew G Krebs, Louise Carter, Shaun Villa, Amy King, Clare Massey, James Lorens, Emma Darlington
- Abstract
Loading...